Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Other financing activities (2024)

Kairos Pharma (KAPA) has disclosed Other financing activities for 1 consecutive years, with $348000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Other financing activities changed N/A year-over-year to $348000.0, compared with a TTM value of $390000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $390000.0, down 8.24% over the prior year.
  • Other financing activities was $348000.0 for Q3 2024 at Kairos Pharma, up from -$47000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $348000.0 in Q3 2024 and bottomed at -$47000.0 in Q2 2024.